The Gestational Diabetes Mellitus Approach in Clinical Practice – A Narrative Review

1. Negrato CA, Gomes MB. Historical facts of screening and diagnosing diabetes in pregnancy. Diabetol Metab Syndr. 2013; 5:2210.1186/1758-5996-5-22364450023634949Search in Google Scholar

2. Ramírez-Torres MA. The importance of gestational diabetes beyond pregnancy. Nutr Rev. 2013; 71 Suppl 1:S37-S4110.1111/nure.1207024147923Search in Google Scholar

3. Hoet JP, Lukens FD. Carbohydrate metabolism during pregnancy. Diabetes. 1954;3:1-1210.2337/diab.3.1.113141877Search in Google Scholar

4. Mack LR, Tomich PG. Gestational Diabetes: Diagnosis, Classification, and Clinical Care. Obstet Gynecol Clin North Am. 2017; 44(2):207-21710.1016/j.ogc.2017.02.00228499531Search in Google Scholar

5. Mirghani Dirar A, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017; 8(12):489-51110.4239/wjd.v8.i12.489574009429290922Search in Google Scholar

6. Behboudi-Gandevani S, Parajuli R, Vaismoradi M. A systematic review of the prevalence of gestational diabetes in Norway. Int. J. Environ. Res. Public Health. 2021; 18(4):1423Search in Google Scholar

7. Lewandowska M. Gestational Diabetes Mellitus (GDM) Risk for Declared Family History of Diabetes, in Combination with BMI Categories. Int. J. Environ. Res. Public Health. 2021; 18(13):693610.3390/ijerph18136936829380534203509Search in Google Scholar

8. Eman M. Alfadhli. Gestational diabetes mellitus. Saudi Med J. 2015; 36 (4):399-40610.15537/smj.2015.4.10307440447225828275Search in Google Scholar

9. Franz M, Polterauer M, Springer S, et al. Maternal and neonatal omentin-1 levels in gestational diabetes, Arch Gynecol Obstet. 2018; 297(4):885-88910.1007/s00404-018-4652-5584964429335783Search in Google Scholar

10. Souvannavong-Vilivong X, Sitticharoon C, Klinjampa R, et al. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM. Acta Diabetol. 2019; 56(10):1121-113110.1007/s00592-019-01355-031076892Search in Google Scholar

11. Radzicka S, Pietryga M, Iciek R, Brązert J. The role of visfatin in pathogenesis of gestational diabetes (GDM). Ginekol Pol. 2018;89(9):518-52110.5603/GP.a2018.008830318580Search in Google Scholar

12. Bozkurt L, Göbl CS, Baumgartner-Parzer S, Luger A, Pacini G, Kautzky-Willer A. Adiponectin and leptin at early pregnancy: association to actual glucose disposal and risk for GDM-A prospective cohort study. Int J Endocrinol. 2018; 2018:546376210.1155/2018/5463762Search in Google Scholar

13. Lorenzo-Almorós A, Hang T, Peiró C, et al. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019;18(1):14010.1186/s12933-019-0935-9Search in Google Scholar

14. Stanirowski PJ, Szukiewicz D, Pyzlak M, et al. Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta. Endocrine. 2017;55(3):799-80810.1007/s12020-016-1202-4Search in Google Scholar

15. American Diabetes Association Diabetes Care. Diabetes Care Jan. 2021; 44 (Supplement 1) S200-S210Search in Google Scholar

16. El Sagheera GM, Hamdi L. Prevalence and risk factors for gestational diabetes mellitus according to the Diabetes in Pregnancy Study Group India in comparison to International Association of the Diabetes and Pregnancy Study Groups in El-Minya, Egypt J Intern Med. 2018;30:131–13910.4103/ejim.ejim_11_18Search in Google Scholar

17. Moore LE, Voaklander B, Savu A, et al. Association between the antepartum oral glucose tolerance test and the risk of future diabetes mellitus among women with gestational diabetes: A systematic review and meta-analysis. J Diabetes Complications. 2021;35(4):10780410.1016/j.jdiacomp.2020.107804Search in Google Scholar

18. Giannakou K, Evangelou E, Yiallouros P, et al. Risk factors for gestational diabetes: An umbrella review of meta-analyses of observational studies. PLoS One. 2019;14(4):e021537210.1371/journal.pone.0215372Search in Google Scholar

19. Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends Endocrinol Metab. 2018;29(11):743-75410.1016/j.tem.2018.09.004Search in Google Scholar

20. Sweeting AN, Ross GP, Hyett J, et al. Baseline HbA1C to Identify High-Risk Gestational Diabetes: Utility in Early vs Standard Gestational Diabetes. J Clin Endocrinol Metab. 2017;102(1):150-156Search in Google Scholar

21. Casey Brian. Gestational Diabetes — On Broadening the Diagnosis. N Engl J Med. 2021;384:965-96610.1056/NEJMe2100902Search in Google Scholar

22. Farrar D, Duley L, Dowswell T, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev. 2017;8(8):CD00712210.1002/14651858.CD007122.pub4Search in Google Scholar

23. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–77310.1016/0002-9378(82)90349-0Search in Google Scholar

24. Benhalima K, Van Crombrugge P, Moyson C, et al. The Sensitivity and Specificity of the Glucose Challenge Test in a Universal Two-Step Screening Strategy for Gestational Diabetes Mellitus Using the 2013 World Health Organization Criteria. Diabetes Care. 2018;41(7):e111-e11210.2337/dc18-055629748432Search in Google Scholar

25. Napoli A, Sciacca L, Pintaudi B, et al. Screening of postpartum diabetes in women with gestational diabetes: high-risk subgroups and areas for improvements-the STRONG observational study. Acta Diabetol. 2021 Apr 12Search in Google Scholar

26. Goueslard K, Cottenet J, Mariet AS, et al. Early screening for type 2 diabetes following gestational diabetes mellitus in France: hardly any impact of the 2010 guidelines. Acta Diabetol. 2017;54(7):645-65110.1007/s00592-017-0986-x28393277Search in Google Scholar

27. American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021;44(Suppl.1):S15-S3310.2337/dc21-S00233298413Search in Google Scholar

28. Thayer SM, Lo JO, Caughey AB. Gestational Diabetes: Importance of Follow-up Screening for the Benefit of Long-term Health. Obstet Gynecol Clin North Am. 2020;47(3):383-39610.1016/j.ogc.2020.04.002748659632762924Search in Google Scholar

29. Khalifeh A, Eckler R, Felder L, Saccone G, Caissutti C, Berghella V. One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2020;33(4):612-61710.1080/14767058.2018.149848029985079Search in Google Scholar

30. Sert UY, Ozgu-Erdinc AS. Gestational Diabetes Mellitus Screening and Diagnosis. Adv Exp Med Biol. 2021;1307:231-25510.1007/5584_2020_51232314318Search in Google Scholar

31. Kuo CH, Li HY. Diagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence. Curr Diab Rep. 2019;19(12):15510.1007/s11892-019-1271-x31802260Search in Google Scholar

32. Mission JF, Ohno MS, Cheng YW, Caughey AB. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol. 2012;207(4):326.e1-910.1016/j.ajog.2012.06.048462125922840972Search in Google Scholar

33. Satodiya M, Takkar N, Goel P, Kaur J. Comparison of One-Step Versus Two-Step Screening for Diagnosis of GDM in Indian Population: A Randomized Controlled Trial. J Obstet Gynaecol India. 2017;67(3):190-19510.1007/s13224-016-0955-2542564228546666Search in Google Scholar

34. Ogunleye OK, Davidson KD, Gregg AR, Egerman RS. Perinatal outcomes after adopting 1- versus 2-step approach to diagnosing gestational diabetes. J Matern Fetal Neonatal Med. 2017;30(2):186-19010.3109/14767058.2016.116620127022779Search in Google Scholar

35. Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016;102:47-5010.1016/j.earlhumdev.2016.09.007Search in Google Scholar

36. Bateman BT, Patorno E, Desai RJ, et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations. Obstet Gynecol. 2017;129:174–18410.1097/AOG.0000000000001775Search in Google Scholar

37. Kazmin A, Garcia-Bournissen F, Koren G. Risks of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can. 2007;29:906–90810.1016/S1701-2163(16)32656-1Search in Google Scholar

38. Auvinen AM, Luiro K, Jokelainen J, et al. Type 1 and type 2 diabetes after gestational diabetes: a 23 year cohort study. Diabetologia. 2020;63(10):2123-212810.1007/s00125-020-05215-3747698532725280Search in Google Scholar

39. Aagaard KA, Al-Far HM, Piscator U, et al. Manifest diabetes after gestational diabetes: a double-cohort, long-term follow-up in a Danish population. Arch Gynecol Obstet. 2020;302(5):1271-127810.1007/s00404-020-05669-132656592Search in Google Scholar

40. Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev. 2005;3(2):104-13Search in Google Scholar

41. Alvarez-Bulnes O, Monés-Llivina A, Cavero-Roig L, et al. Ophthalmic Pathology in the Offspring of Pregnant Women with Gestational Diabetes Mellitus. Matern Child Health J. 2020;24(4):524-52910.1007/s10995-020-02887-631997119Search in Google Scholar

42. Bianchi C, Taricco E, Cardellicchio M, et al. The role of obesity and gestational diabetes on placental size and fetal oxygenation. Placenta. 2021;103:59-6310.1016/j.placenta.2020.10.01333080447Search in Google Scholar

43. Parsons J, Sparrow K, Ismail K, et al. Experiences of gestational diabetes and gestational diabetes care: a focus group and interview study, Parsons et al. BMC Pregnancy Childbirth. 2018; 18:2510.1186/s12884-018-1657-9576559729325518Search in Google Scholar

44. Szmuilowicz ED, Josefson JL, Metzger BE. Gestational diabetes mellitus. Endocrinol. Metab. Clin. N. Am. 2019; 48:479–493Search in Google Scholar

45. Institute of Medicine. 2009. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies PressSearch in Google Scholar

46. Lamminpää R, Vehviläinen-Julkunen K, Schwab U. A systematic review of dietary interventions for gestational weight gain and gestational diabetes in overweight and obese pregnant women. Eur J Nutr. 2018;57(5):1721-173610.1007/s00394-017-1567-z606081529128995Search in Google Scholar

47. Farabi SS, Hernandez TL. Low-Carbohydrate Diets for Gestational Diabetes. Nutrients. 2019;11(8):173710.3390/nu11081737672358531357598Search in Google Scholar

48. Rasmussen L, Poulsen CW, Kampmann U, Smedegaard SB, Ovesen PG, Fuglsang J. Diet and Healthy Lifestyle in the Management of Gestational Diabetes Mellitus. Nutrients. 2020;12(10):305010.3390/nu12103050759968133036170Search in Google Scholar

49. Yong HY, Mohd Shariff Z, Mohd Yusof BN, et al. High physical activity and high sedentary behavior increased the risk of gestational diabetes mellitus among women with excessive gestational weight gain: a prospective study. BMC Pregnancy Childbirth. 2020;20(1):59710.1186/s12884-020-03299-8754126033028258Search in Google Scholar

50. Barakat R, Refoyo I, Coteron J, Franco E. Exercise during pregnancy has a preventative effect on excessive maternal weight gain and gestational diabetes. A randomized controlled trial. Braz J Phys Ther. 2019;23(2):148-15510.1016/j.bjpt.2018.11.005642890830470666Search in Google Scholar

51. Malek R, Davis SN. Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. Expert Opin Drug Metab Toxicol. 2016;12(6):691-910.1080/17425255.2016.118713127163280Search in Google Scholar

52. Barbour LA, Scifres C, Valent AM, et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol. 2018;219(4):367.e1-367.e710.1016/j.ajog.2018.06.013626393629959933Search in Google Scholar

53. Barbour LA, Feig DS. Metformin for Gestational Diabetes Mellitus: Progeny, Perspective, and a Personalized Approach, Diabetes Care. 2019; 42(3): 396-39910.2337/dci18-005530787061Search in Google Scholar

54. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358: 2003-201510.1056/NEJMoa070719318463376Search in Google Scholar

55. Guo L, Ma J, Tang J, et al. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis. J Diabetes Res. 2019;2019:980470810.1155/2019/9804708687501931781670Search in Google Scholar

56. Farrar D, Simmonds M, Bryant M, et al. Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open. 2017;7(6):e01555710.1136/bmjopen-2016-015557573442728647726Search in Google Scholar

57. Guo L, Ma J, Tang J, Hu D, Zhang W, Zhao X. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis. J Diabetes Res. 2019;2019:98047010.1155/2019/9804708Search in Google Scholar

58. Ghomian N, Vahed SHM, Firouz S, Yaghoubi MA, Mohebbi M, Sahebkar A. The efficacy of metformin compared with insulin in regulating blood glucose levels during gestational diabetes mellitus: A randomized clinical trial. J Cell Physiol. 2019;234(4):4695-470110.1002/jcp.2723830191995Search in Google Scholar

59. Sales WB, Nascimento IBD, Dienstmann G, Souza MLR, Silva GDD, Silva JC. Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women. Rev Bras Ginecol Obstet. 2018;40(4):180-18710.1055/s-0038-164263229702716Search in Google Scholar

60. Renz PB, Chume FC, Timm JRT, et al. Diagnostic accuracy of glycated hemoglobin for gestational diabetes mellitus: a systematic review and meta-analysis. Clin Chem Lab Med. 2019;57(10):1435-144910.1515/cclm-2018-119130893053Search in Google Scholar

61. Szmuilowicz ED, Josefson JL, Metzger BE. Gestational Diabetes Mellitus. Endocrinol Metab Clin North Am. 2019;48(3):479-49310.1016/j.ecl.2019.05.001700846731345518Search in Google Scholar

62. Subiabre M, Silva L, Toledo F, et al. Insulin therapy and its consequences for the mother, foetus, and newborn in gestational diabetes mellitus. Biochim Biophys Acta Mol Basis Dis. 2018;1864(9 Pt B):2949-295610.1016/j.bbadis.2018.06.00529890222Search in Google Scholar

63. ACOG Practice Bulletin No. 190. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018;131:e49–6410.1097/AOG.000000000000250129370047Search in Google Scholar

64. Ringholm L, Damm P, Mathiesen ER. Improving pregnancy outcomes in women with diabetes mellitus: modern management. Nat Rev Endocrinol. 2019;15(7):406-41610.1038/s41574-019-0197-330948803Search in Google Scholar

65. Huang SY, Yu B, He X, Chen Y. Intrapartum Results on Differing Degrees of Ketonuria in Nulliparous Women with Gestational Diabetes Mellitus during Spontaneous Labor. Int J Endocrinol. 2019;2019:720701210.1155/2019/7207012688521931827509Search in Google Scholar

66. Anastasiou E, Farmakidis G, Gerede A, et al. Clinical practice guidelines on diabetes mellitus and pregnancy: II. Gestational diabetes mellitus. Hormones (Athens). 2020;19(4):601-60710.1007/s42000-020-00193-y32451981Search in Google Scholar

67. Zaharieva DP, Teng JH, Ong ML, et al. Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose to Assess Glycemia in Gestational Diabetes. Diabetes Technol Ther. 2020;22(11):822-82710.1089/dia.2020.007332324046Search in Google Scholar

68. Scott EM, Feig DS, Murphy HR, Law GR, CONCEPTT Collaborative Group. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes. Diabetes Care. 2020;43(6):1178-118410.2337/dc19-2527724535632209645Search in Google Scholar